Ivan Marchitelli

ORCID: 0000-0002-2271-8414
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Colorectal Cancer Treatments and Studies
  • Pancreatic and Hepatic Oncology Research
  • Colorectal Cancer Surgical Treatments
  • MRI in cancer diagnosis
  • Colorectal Cancer Screening and Detection
  • Oral and gingival health research
  • Inflammatory Biomarkers in Disease Prognosis
  • Gastric Cancer Management and Outcomes
  • Liver Disease and Transplantation
  • Pediatric Hepatobiliary Diseases and Treatments
  • Cancer Diagnosis and Treatment
  • Advances in Oncology and Radiotherapy
  • Liver physiology and pathology
  • Gallbladder and Bile Duct Disorders
  • Viral-associated cancers and disorders
  • Pancreatitis Pathology and Treatment
  • Alcohol Consumption and Health Effects
  • Radiomics and Machine Learning in Medical Imaging
  • MicroRNA in disease regulation
  • Multiple and Secondary Primary Cancers

Hôpitaux Universitaires de Strasbourg
2025

Université de Strasbourg
2025

Collaborative Group (United States)
2024

University of Verona
2020-2023

Institute Mutualiste Montsouris
2023

Ospedale G.B. Morgagni - L.Pierantoni
2022

Ospedale di Parma
2022

University of Parma
2022

Sidney Kimmel Cancer Center
2022

Hospital Regional Universitario de Málaga
2022

Clear indications on how to select retreatments for recurrent hepatocellular carcinoma (HCC) are still lacking.To create a machine learning predictive model of survival after HCC recurrence allocate patients their best potential treatment.Real-life data were obtained from an Italian registry between January 2008 and December 2019 median (IQR) follow-up 27 (12-51) months. External validation was made derived by another cohort Japanese cohort. Patients who experienced first surgical approach...

10.1001/jamasurg.2022.6697 article EN JAMA Surgery 2022-12-28

The relationship between immune-nutritional status and tumor growth; biological aggressiveness survival, is still debated. Therefore, this study aimed to evaluate the prognostic performance of different inflammatory markers in patients who underwent surgery for biliary tract cancer (BTC). role following were investigated: Glasgow Prognostic Score (GPS), modified (mGPS), Index (PI), Neutrophil Lymphocyte ratio (NLR), Platelet (PLR), Monocyte (LMR), Nutritional (PNI). A total 282 undergoing...

10.3390/cancers13143594 article EN Cancers 2021-07-18

10.1016/j.hpb.2023.06.004 article EN HPB 2023-06-13
Coming Soon ...